SUN Pharmaceutical Industries Limited Syringe Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Syringe Export Records India — #4 Exporter, 99 Shipments, $5.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Syringe

India Pharmaceutical Trade Intelligence

$179.9M291 Suppliers154 CountriesHS 30049099

ExportsIndia → UNITED STATES36.7%India → BELGIUM14.1%

#1 Buyer: FRESENIUS KABI

SUN Pharmaceutical Industries Limited — Syringe Exporter #4 | $5.0M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Syringe Exporter Profile

Indian Pharmaceutical Exporter · #4 for Syringe · $5.0M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Syringe with $5.0M in export value and 99 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.8% market share in Syringe exports across 6 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Syringe Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Syringe export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Syringe?

Country	Value	Shipments	Share
BELGIUM	$4.6M	97	93.9%
NEW ZEALAND	$150.0K	3	3.0%
AUSTRALIA	$100.0K	2	2.0%
ROMANIA	$50.0K	1	1.0%
HUNGARY	$364	3

Who Are the Top Buyers of Syringe from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$4.6M	95
SUN PHARMA ANZ PTY LTD	AUSTRALIA	$100.0K	2
DOUGLAS PHARMACEUTICALS LTD	NEW ZEALAND	$100.0K	2
YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN	BELGIUM	$55.6K	2
M/S. DOUGLAS PHARMACEUTICALS LTD.	NEW ZEALAND	$50.0K	1
TERAPIA S A	ROMANIA	$50.0K	1
ALKALOIDA VEGYESZETI GYAR ZRT.	HUNGARY	$329	1
TO THE ORDER OF	SIERRA LEONE	$155	1
NOVOCHEMIX BIOMEDIC LLC	RUSSIA	$52	1
ALKALOIDA CHEMICAL COMPANY ZRT.,	HUNGARY	$35	2

SUN Pharmaceutical Industries Limited supplies Syringe to 10 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by SUN PHARMA ANZ PTY LTD (AUSTRALIA) and DOUGLAS PHARMACEUTICALS LTD (NEW ZEALAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Syringe Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
SUMATRIPTAN SUN 6 MG/ 0.5 ML SUMATRIPTAN SUCCINATE INJECTION 6 MG/ 0.5 ML PREFILLED SYRINGE PACK : PA 02SYRIS BATCH D	$250.0K	5
SUMATRIPTAN SUN 6MG/0.5ML SUMATRIPTAN SUCCINATE INJECTION 6 MG/ 0.5 ML PREFILLED SYRINGE PACK : PA 02SYRIS BATCH DETA	$200.0K	4
SUMATRIPTAN SUN 6 MG/ 0.5 ML (SUMATRIPTAN SUCCINATE INJECTION 6 MG/ 0.5 ML PREFILLED SYRINGE)-GST INVOICE NO	$200.0K	4
SUMATRIPTAN SUN 6MG/0.5ML (SUMATRIPTAN SUCCINATE INJECTION 6 MG/ 0.5 ML PREFILLED SYRINGE) PACK : PA 02SYRIS (BATCH DETANOS	$150.0K	3
TEMPIL 6MG INJ 112 PFS DE (SUMATRIPTANSUCCINATE INJECTION 6 MG/ 0.5 ML PREFILLED SYRINGE) PACK : 0112 (BATCH DETAILSNOS	$150.0K	3
SUMATRIPTAN SUN 6MG/0.5ML (SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML PREFILLED SYRINGE ) PACK : PA 02SYRIS (BATCH DETAILNOS	$150.0K	3
SUMATRIPTAN 12MG/ML 32 PFS NO-SE (SUMATRIPTAN SUCCINATE INJECTION 12 MG/ML PREFILLED SYRINGE) PACK : 0302 (BATCH DETAINOS	$150.0K	3
SUMATRIPTAN SUN 6 MG/ 0.5 ML (SUMATRIPTAN SUCCINATE INJECTION 6 MG/ 0.5 ML PREFILLED SYRINGE) PACK : PA 02SYRIS (BATCH DNOS	$150.0K	3
SUMATRIPTAN SUN 6 MG/ 0.5 ML (SUMATRIPTAN SUCCINATE INJECTION 6 MG/ 0.5 ML PREFILLED SYRINGE) PACK :PA 02SYRIS (250 SHIP	$150.0K	3
SUMATRIPTAN SUN 6MG/0.5ML(SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML PREFILLED SYRINGE) PACK :PA 02SYRIS (249 SHIPPERS ON	$150.0K	3

SUN Pharmaceutical Industries Limited exports 66 distinct Syringe formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SUMATRIPTAN SUN 6 MG/ 0.5 ML SUMATRIPTAN SUCCINATE INJECTION with 5 shipments worth $250.0K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Syringe Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	GLAND PHARMA LIMITED	$11.7M	234	19	$50.0K
3	INDIAN IMMUNOLOGICALS LIMITED	$7.9M	158	20	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$5.0M	99	6	$50.0K
8	BRAWN LABORATORIES LIMITED	$3.1M	62	5	$50.0K
9	CONTACARE OPHTHALMICS AND DIAGNOSTICS	$1.9M	290	30	$6.7K

SUN Pharmaceutical Industries Limited ranks #4 among 291 Indian Syringe exporters. Average shipment value of $50.0K compared to the market average of $231.1K. The closest competitors by value are GLAND PHARMA LIMITED and INDIAN IMMUNOLOGICALS LIMITED.

Which Indian Ports Ship Syringe Exports?

Port	Shipments	% Share
HYDERABAD ICD	447	12.7%
SAHAR AIR CARGO ACC (INBOM4)	290	8.2%
SAHAR AIR	282	8.0%
AHEMDABAD AIR	219	6.2%
AHEMDABAD AIR ACC (INAMD4)	209	5.9%
DELHI AIR	187	5.3%
NHAVA SHEVA SEA (INNSA1)	138	3.9%
HYDERABAD ICD (INSNF6)	127	3.6%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Syringe Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Syringe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 108 individual customs records matching SUN Pharmaceutical Industries Limited exporting Syringe, covering 66 formulations to 7 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 154+ countries, 751+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Syringe

Syringe

SUN Pharmaceutical Industries Limited — Syringe Exporter Profile

SUN Pharmaceutical Industries Limited — Syringe Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Syringe?

Who Are the Top Buyers of Syringe from SUN Pharmaceutical Industries Limited?

What Is India's Total Syringe Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Syringe Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Syringe Exporters?

What Syringe Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Syringe to Key Markets

Australia — TGA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Syringe Exporters?

Which Indian Ports Ship Syringe Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Syringe Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Syringe Export Data from SUN Pharmaceutical Industries Limited

Syringe Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source